A RAVAX Phase 3, Multicenter, Switch Assessment of Sequential Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment With Etanercept (ENBREL) or Adalimumab (HUMIRA)
Latest Information Update: 12 Dec 2013
At a glance
- Drugs IR 501 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Immune Response BioPharma
- 12 Dec 2013 New trial record